Publications by authors named "K Muru"

Over two dozen spliceosome proteins are involved in human diseases, also referred to as spliceosomopathies. WW domain-binding protein 4 (WBP4) is part of the early spliceosomal complex and has not been previously associated with human pathologies in the Online Mendelian Inheritance in Man (OMIM) database. Through GeneMatcher, we identified ten individuals from eight families with a severe neurodevelopmental syndrome featuring variable manifestations.

View Article and Find Full Text PDF

Objective: To assess the prevalence of congenital anomalies (CAs), chromosomal abnormalities and monogenic diseases among births and terminated pregnancies due to fetal anomalies (TOPFA) in 2020 in Estonia. Up to 2020 no data on prevalence of CAs in Estonia is reported.

Methods: For retrospective observational study data of all births and terminations of pregnancies after 12th gestational week from (i) the Estonian Medical Birth Registry, (ii) Abortion Registy, (iii) Health Insurance Fund and (iv) hospital records were linked.

View Article and Find Full Text PDF
Article Synopsis
  • Over two dozen proteins involved in the spliceosome are linked to human diseases, known as spliceosomopathies; WBP4 is a newly identified protein associated with severe neurodevelopmental syndromes.
  • Researchers identified eleven patients from eight families affected by hypotonia, developmental delays, intellectual disabilities, and various organ abnormalities, confirming that mutations in WBP4 are a key factor.
  • Genetic analyses revealed loss-of-function variants leading to a complete loss of WBP4 protein, affecting RNA splicing in genes related to the nervous and musculoskeletal systems, highlighting the need for further studies on the disease mechanisms.
View Article and Find Full Text PDF

Accurate diagnosis for patients living with neurodevelopmental disorders is often met with numerous challenges, related to the ambiguity of findings and lack of specificity in genetic variants leading to pathology. Genome-wide DNA methylation analysis has been used to develop highly sensitive and specific 'episignatures' as biomarkers capable of differentiating and classifying complex neurodevelopmental disorders. In this study we describe distinct episignatures for KAT6A syndrome, caused by pathogenic variants in the lysine acetyltransferase A gene (), and for the two neurodevelopmental disorders associated with lysine acetyl transferase B ().

View Article and Find Full Text PDF

Introduction: Epilepsy is a common central nervous system disorder characterized by abnormal brain electrical activity. We aimed to compare the metabolic profiles of plasma from patients with epilepsy across different etiologies, seizure frequency, seizure type, and patient age to try to identify common disrupted pathways.

Material And Methods: We used data from three separate cohorts.

View Article and Find Full Text PDF